These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 37994750)

  • 21. Precision medicine in colorectal cancer: Leveraging multi-omics, spatial omics, and artificial intelligence.
    Xu Z; Li W; Dong X; Chen Y; Zhang D; Wang J; Zhou L; He G
    Clin Chim Acta; 2024 Jun; 559():119686. PubMed ID: 38663471
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Application of omics technologies in dermatological research and skin management.
    He J; Jia Y
    J Cosmet Dermatol; 2022 Feb; 21(2):451-460. PubMed ID: 33759323
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Proteomic research in sarcomas - current status and future opportunities.
    Burns J; Wilding CP; L Jones R; H Huang P
    Semin Cancer Biol; 2020 Apr; 61():56-70. PubMed ID: 31722230
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multi-omics strategies for personalized and predictive medicine: past, current, and future translational opportunities.
    Ahmed Z
    Emerg Top Life Sci; 2022 Apr; 6(2):215-225. PubMed ID: 35234253
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Omics Data and Their Integrative Analysis to Support Stratified Medicine in Neurodegenerative Diseases.
    La Cognata V; Morello G; Cavallaro S
    Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34062930
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Renal injury in neonates: use of "omics" for developing precision medicine in neonatology.
    Joshi MS; Montgomery KA; Giannone PJ; Bauer JA; Hanna MH
    Pediatr Res; 2017 Jan; 81(1-2):271-276. PubMed ID: 27723726
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical genomic profiling to identify actionable alterations for investigational therapies in patients with diverse sarcomas.
    Groisberg R; Hong DS; Holla V; Janku F; Piha-Paul S; Ravi V; Benjamin R; Kumar Patel S; Somaiah N; Conley A; Ali SM; Schrock AB; Ross JS; Stephens PJ; Miller VA; Sen S; Herzog C; Meric-Bernstam F; Subbiah V
    Oncotarget; 2017 Jun; 8(24):39254-39267. PubMed ID: 28424409
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Biological determinants of health: Genes, microbes, and metabolism exemplars of nursing science.
    Ferranti EP; Grossmann R; Starkweather A; Heitkemper M
    Nurs Outlook; 2017; 65(5):506-514. PubMed ID: 28576296
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histiocytic and Dendritic Cell Sarcomas of Hematopoietic Origin Share Targetable Genomic Alterations Distinct from Follicular Dendritic Cell Sarcoma.
    Massoth LR; Hung YP; Ferry JA; Hasserjian RP; Nardi V; Nielsen GP; Sadigh S; Venkataraman V; Selig M; Friedmann AM; Samore W; Killian JK; Milante R; Giessinger J; Foley-Peres K; Marcus C; Severson E; Duncan D; Sivakumar S; Ross JS; Desphande V; Ramkissoon SH; Vergilio JA; Louissaint A; Zukerberg LR; Williams EA
    Oncologist; 2021 Jul; 26(7):e1263-e1272. PubMed ID: 33904632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. From Omics to Multi-Omics Approaches for In-Depth Analysis of the Molecular Mechanisms of Prostate Cancer.
    Nevedomskaya E; Haendler B
    Int J Mol Sci; 2022 Jun; 23(11):. PubMed ID: 35682963
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Integration of pan-omics technologies and three-dimensional in vitro tumor models: an approach toward drug discovery and precision medicine.
    Jose A; Kulkarni P; Thilakan J; Munisamy M; Malhotra AG; Singh J; Kumar A; Rangnekar VM; Arya N; Rao M
    Mol Cancer; 2024 Mar; 23(1):50. PubMed ID: 38461268
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patient-specific multi-omics models and the application in personalized combination therapy.
    John A; Qin B; Kalari KR; Wang L; Yu J
    Future Oncol; 2020 Aug; 16(23):1737-1750. PubMed ID: 32462937
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Overcoming multiple myeloma drug resistance in the era of cancer 'omics'.
    Guang MHZ; McCann A; Bianchi G; Zhang L; Dowling P; Bazou D; O'Gorman P; Anderson KC
    Leuk Lymphoma; 2018 Mar; 59(3):542-561. PubMed ID: 28610537
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiomics Data Triangulation for Asthma Candidate Biomarkers and Precision Medicine.
    Pecak M; Korošec P; Kunej T
    OMICS; 2018 Jun; 22(6):392-409. PubMed ID: 29927718
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Precision medicine with multi-omics strategies, deep phenotyping, and predictive analysis.
    Ahmed Z
    Prog Mol Biol Transl Sci; 2022; 190(1):101-125. PubMed ID: 36007996
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Integrative omics of schizophrenia: from genetic determinants to clinical classification and risk prediction.
    Guan F; Ni T; Zhu W; Williams LK; Cui LB; Li M; Tubbs J; Sham PC; Gui H
    Mol Psychiatry; 2022 Jan; 27(1):113-126. PubMed ID: 34193973
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Assessment of Predictive Biomarkers of the Response to Pazopanib Based on an Integrative Analysis of High-grade Soft-tissue Sarcomas: Analysis of a Tumor Sample from a Responder and Patients with Other Soft-tissue Sarcomas.
    Suehara Y; Kohsaka S; Yamaguchi S; Hayashi T; Kurihara T; Sano K; Sasa K; Akaike K; Ueno T; Kojima S; Ikegami M; Mizuno S; Okubo T; Kim Y; Kaneko K; Saito T; Kato S; Mano H
    Clin Orthop Relat Res; 2020 Nov; 478(11):2461-2476. PubMed ID: 32567826
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Personalized Medicine Applied to Forensic Sciences: New Advances and Perspectives for a Tailored Forensic Approach.
    Santurro A; Vullo AM; Borro M; Gentile G; La Russa R; Simmaco M; Frati P; Fineschi V
    Curr Pharm Biotechnol; 2017; 18(3):263-273. PubMed ID: 28176637
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unveiling the potential of proteomic and genetic signatures for precision therapeutics in lung cancer management.
    Srivastava S; Jayaswal N; Kumar S; Sharma PK; Behl T; Khalid A; Mohan S; Najmi A; Zoghebi K; Alhazmi HA
    Cell Signal; 2024 Jan; 113():110932. PubMed ID: 37866667
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.